瘤微环境响应纳米颗粒:有前途的癌症 PTT载体
Heming Sun1, Yuebo Li2,3, Ming Xue2,3
1Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, 100029, People's Republic of China.
International journal of nanomedicine
|June 30, 2025
概括
针对瘤微环境 (TME) 的响应性纳米药物提供了新的癌症治疗策略. 将对TME敏感的纳米药物与光热疗法 (PTT) 结合起来,有望克服耐药性并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 生物医学工程 生物医学工程
背景情况:
- 瘤微环境 (TME) 提出了独特的挑战,包括缺氧,低pH值和酶过度表达.
- 这些TME特征促进瘤生长,转移和耐药性,限制了传统疗法.
- TME的独特特征也为有针对性的纳米医学干预提供了机会.
研究的目的:
- 审查TME的主要特征.
- 探索用于癌症治疗的TME响应纳米药物的最新进展.
- 评估这些纳米药物与光热疗法 (PTT) 和化疗相结合的潜力.
主要方法:
- 对TME特征的文献综述.
- 对针对TME的纳米医学策略的分析.
- 对TME响应纳米药物的评估,用于PTT和化疗的联合治疗.
主要成果:
- 可以设计对TME敏感的纳米药物,以利用特定的瘤微环境特征.
- 使用对TME敏感的纳米药物与PTT和化疗的组合疗法显示出多模式抗瘤效应的潜力.
- 这些方法可以克服传统癌症治疗的局限性.
结论:
- 响应TME的纳米药物对提高癌症治疗疗效具有显著的前景.
- 纳米医学与PTT的整合为多模式癌症治疗提供了一个可行的策略.
- 对TME响应纳米材料的进一步研究对于临床转化和改善患者治疗结果至关重要.
更多相关视频
06:42Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution
Published on: May 9, 2025
682
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.1K
相关概念视频
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
01:27Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667